Areteia Therapeutics
PrivateLast Round
Series A
Extension
Feb 13, 2024
Total Funding Raised
$425M
Company Overview
Areteia Therapeutics is a biotechnology company that develops oral medications for the treatment of eosinophilic asthma and related inflammatory airway diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Areteia Therapeutics Comparables
Compare Areteia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Knopp Biosciences | 91% | |
| RAPT Therapeutics | 69% | |
| Roche Holding | 68% | |
Areteia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 13, 2024 | ||||
| Series A | Jul 12, 2022 |
Key People
Founding team and executive leadership
Areteia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Capital | Series A, Series A Extension |
| Access Industries | Series A, Series A Extension |
| Bain Capital Life Sciences | Series A, Series A Extension |
| GV | Series A, Series A Extension |
| Maverick Capital | Series A, Series A Extension |
| ARCH Venture Partners | Series A, Series A Extension |
| Viking Global Investors | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2025
Ian F. Smith appointed Chair of the Audit Committee.
- Mar 26, 2025
Donald J. Hayden, Jr. appointed as Chair of the Board.
Areteia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Areteia Therapeutics's valuation, stock price, and market status.